Search results for "controlled"

showing 10 items of 2729 documents

Improving Efficacy of PubMed Clinical Queries for Retrieving Scientifically Strong Studies on Treatment

2006

The authors evaluated the retrieval power of PubMed "Clinical Queries," narrow search string, about therapy in comparison with a modified search string to avoid possible retrieval bias. PubMed search strategy was compared to a slightly modified string that included the Britannic English term "randomised." The authors tested the two strings joined onto each of four terms concerning topics of broad interest: hypertension, hepatitis, diabetes, and heart failure. In particular, precision was computed for not-indexed citations. The added word "randomised" improved total citation retrieval in any case. Total retrieval gain for not-indexed citations ranged from 11.1% to 21.4%. A significant number…

Information retrievalbusiness.industryString (computer science)MEDLINEHealth InformaticsString searching algorithmTerm (time)law.inventionRandomized controlled triallawMedicinePubMed Clinical Queries modified string term “randomised"businessCitationJournal of the American Medical Informatics Association
researchProduct

An Electrooculography based Human Machine Interface for wheelchair control

2019

International audience; This paper presents a novel single channel Electrooculography (EOG) based efficient Human–Machine Interface (HMI) for helping the individuals suffering from severe paralysis or motor degenerative diseases to regain mobility. In this study, we propose a robust system that generates control command using only one type of asynchronous eye activity (voluntary eye blink) to navigate the wheelchair without a need of graphical user interface. This work demonstrates a simple but robust and effective multi-level threshold strategy to generate control commands from multiple features associated with the single, double and triple voluntary eye blinks to control predefined action…

Information transfermedicine.diagnostic_testbusiness.industryComputer scienceInterface (computing)0206 medical engineeringControl (management)Biomedical Engineering02 engineering and technologyElectrooculographyHuman Machine InterfaceEOG controlled wheelchairSingle channel BMI020601 biomedical engineeringWheelchairAssistive technologyAsynchronous communication0202 electrical engineering electronic engineering information engineeringmedicine[SDV.IB]Life Sciences [q-bio]/Bioengineering020201 artificial intelligence & image processingbusinessSimulationCommunication channelGraphical user interfaceBiocybernetics and Biomedical Engineering
researchProduct

Self-Immolative Linkers as Caps for the Design of Gated Silica Mesoporous Supports

2016

A new hybrid material based on sulforhodamine-B dye-loaded silica mesoporous nanoparticles capped with a self-immolative gate has been synthesized and characterized. The gated material's controlled release behavior is monitored under different pH conditions. Under acidic and neutral conditions, a low level of dye release is detected. However, at slightly basic pH, significant dye release occurs owing to deprotonation of the phenol moiety in the capping molecule, which results in its disassembly.

Inorganic chemistryNanoparticlemesoporous materials010402 general chemistry01 natural sciencesCatalysisDeprotonationmolecular devicesQUIMICA ORGANICAPolymer chemistryQUIMICA ANALITICAMoietyMolecule010405 organic chemistryChemistryOrganic ChemistryQUIMICA INORGANICApH-responsive systemsGeneral ChemistryControlled release0104 chemical sciencesMesoporous organosilicasilicadyes/pigmentsHybrid materialMesoporous material
researchProduct

Systemic ozone applications, Major autohemotherapy and Rectal Insufflation, evaluated according to the International classification of Evidence-Based…

2019

Now that indications are clearly defined, applications have mostly become standardized and the active mechanisms have been well confirmed, medical ozone application in the form of the low-dose concept, is established and proven as a complementary medical method in the treatment of chronic inflammations or diseases associated with chronic inflammatory conditions.
 More than 11,000 systemic ozone treatments in the form of Major Ozone Autohemotherapy (MAH) in 577 patients and ? 47,000 Rectal Insufflations (RI) in 716 patients in various clinical studies are subjected to critical clinical assessment and classification according to the criteria of evidence-based medicine (EBM).
 Statis…

Insufflationmedicine.medical_specialtyCHRONIC INFLAMMATIONSbusiness.industryEvidence-based medicineBiocompatible materiallaw.inventionAutohemotherapyRandomized controlled triallawmedicineIntensive care medicinebusinessMedical expensesReimbursementJournal of Ozone Therapy
researchProduct

Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.

2017

BACKGROUND Degludec is an ultralong-Acting, once-daily basal insulin that is approved for use in adults, adolescents, and children with diabetes. Previous open-label studies have shown lower day-To-day variability in the glucose-lowering effect and lower rates of hypoglycemia among patients who received degludec than among those who received basal insulin glargine. However, data are lacking on the cardiovascular safety of degludec. METHODS We randomly assigned 7637 patients with type 2 diabetes to receive either insulin degludec (3818 patients) or insulin glargine U100 (3819 patients) once daily between dinner and bedtime in a double-blind, treat-To-Target, event-driven cardiovascular outco…

Insulin degludecBlood GlucoseMalemedicine.medical_treatmentDEVOTE Study GroupInsulin GlargineType 2 diabetesKaplan-Meier Estimate030204 cardiovascular system & hematologylaw.inventiondiabetes ; insulin0302 clinical medicineRandomized controlled triallawCardiovascular DiseaseGLUCOSE CONTROL11 Medical and Health SciencesRISKCOMPLICATIONSOUTCOMESIncidenceGeneral MedicineMiddle AgedInsulin Long-ActingVARIABILITYCardiovascular Diseasesdiabetes mellitusFemaleLife Sciences & BiomedicineHumanmedicine.drugmedicine.medical_specialty030209 endocrinology & metabolismAged; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus Type 2; Double-Blind Method; Female; Humans; Hypoglycemia; Hypoglycemic Agents; Incidence; Insulin Glargine; Insulin Long-Acting; Kaplan-Meier Estimate; Male; Middle Aged; Medicine (all)HypoglycemiaBedtimeArticleEVENTS03 medical and health sciencesHYPOGLYCEMIAMedicine General & InternalDouble-Blind MethodInternal medicineDiabetes mellitusGeneral & Internal MedicinemedicineHumansHypoglycemic AgentsIntensive care medicineMETAANALYSISAgedScience & TechnologyHypoglycemic AgentInsulin glarginebusiness.industryInsulinmedicine.diseaseDiabetes Mellitus Type 2businessBASAL INSULIN
researchProduct

Touchless gestural interfaces for networked public displays

2015

In the near future, we can easily imagine a significant increment in diffusion of networked public displays, as well as novel interaction modalities used in their applications. In the following, we present two of the main challenges related to networked displays we are dealing with, with a particular focus on touchless gestural interfaces: overcoming interaction blindness (i.e. enable users to immediately guess the interactivity of the display, and the gestural nature of it) and performing evaluations in-the-wild (i.e. outside any controlled environment).

Interaction blindnessFocus (computing)ModalitiesNetworked public displaysMultimediaBlindnessTouchless gestural interfacesComputer Networks and CommunicationsComputer scienceEnvironment controlledPublic displayscomputer.software_genremedicine.diseaseTouchless gestural interfaceComputer Networks and CommunicationInteractivityHardware and ArchitectureHuman–computer interactionmedicineExperiments in-the-wild; Interaction blindness; Networked public displays; Touchless gestural interfaces; Computer Networks and Communications; Hardware and Architecture; SoftwareInteraction blindneNetworked public displaycomputerSoftwareExperiments in-the-wildProceedings of the 2015 ACM International Joint Conference on Pervasive and Ubiquitous Computing and Proceedings of the 2015 ACM International Symposium on Wearable Computers - UbiComp '15
researchProduct

2020

Objective To compare surgical success, postoperative intraocular pressure and complication rates between trabeculectomy and XEN gelstent surgery in a cohort of glaucoma patients in a typical clinical setting. Methods A retrospective cohort study of consecutive patients with refractory open-angle glaucoma including patients who underwent either stand-alone XEN gelstent insertion with Mitomycin C or trabeculectomy with Mitomycin C between 2016 and 2018 at the University Eye Hospital Mainz, Germany. Primary outcome measure was the proportion of surgical success 1 year after surgery. Patients with an IOP ≤18mmHg, an intraocular pressure reduction of >20% and in no need of revision surgery or to…

Intraocular pressuremedicine.medical_specialtyMultidisciplinarybusiness.industrymedicine.medical_treatmentGlaucomaRetrospective cohort studymedicine.diseaselaw.inventionTopical medicationSurgery03 medical and health sciences0302 clinical medicineRandomized controlled triallawCohort030221 ophthalmology & optometryMedicineTrabeculectomyComplicationbusiness030217 neurology & neurosurgeryPLOS ONE
researchProduct

Intercurrent factors associated with the development of open-angle glaucoma in The European Glaucoma Prevention Study

2007

Purpose: To evaluate the intercurrent factors for the development of open-angle glaucoma (OAG) in ocular hypertensive patients who were enrolled in the European Glaucoma Prevention Study (EGPS). Design: Randomized, double masked, controlled clinical trial. Methods: setting: Multicenter. study population: A total of 1,077 patients fulfilled a series of inclusion criteria, including intraocular pressure (IOP) 22 to 29 mm Hg, normal and reliable visual fields (VFs) and normal optic disks. intervention: Treatment with dorzolamide or placebo. main outcome measures: Glaucoma-related VF or optic disk changes. Clinical data were collected every six months during a five-year follow-up. Proportional …

Intraocular pressuremedicine.medical_specialtyTime Factorsgenetic structuresOpen angle glaucomaSettore MED/06 - Oncologia MedicaOptic DiskOptic diskOcular hypertensionGlaucomaThiopheneslaw.inventionCorneaDouble-Blind MethodDorzolamideRandomized controlled trialRisk FactorslawOphthalmologyConfidence IntervalsPrevalencemedicineHumansDiureticsglaucoma ocular hypertension intercurrent risk factorsAntihypertensive AgentsIntraocular PressureProportional Hazards ModelsRetrospective StudiesSulfonamidesbusiness.industryHazard ratioRetinal Hemorrhagemedicine.diseaseeye diseasesEuropeOphthalmologyTreatment OutcomeCardiovascular Diseasessense organsbusinessGlaucoma Open-AngleFollow-Up Studiesmedicine.drug
researchProduct

Intravitreal Aflibercept Injection for Macular Edema Resulting from Central Retinal Vein Occlusion

2014

PURPOSE: To evaluate the efficacy and safety of intravitreal aflibercept injections for treatment of macular edema secondary to central retinal vein occlusion (CRVO). DESIGN: A randomized, multicenter, double-masked phase 3 study. PARTICIPANTS: A total of 177 treatment-naive patients with macular edema secondary to CRVO were randomized in a 3:2 ratio. METHODS: Patients received either 2-mg intravitreal aflibercept or sham injections every 4 weeks for 20 weeks. From week 24 to 48, the aflibercept group received aflibercept as needed (pro re nata [PRN]), and the sham group continued receiving sham injections. MAIN OUTCOME MEASURES: The primary efficacy end point was the proportion of patients…

Intraocular pressuremedicine.medical_specialtyVisual acuitygenetic structuresbusiness.industryPhases of clinical researchmedicine.diseaseeye diseases3. Good healthlaw.inventionOphthalmologyCentral retinal vein occlusionRandomized controlled trialPro re natalawOphthalmologymedicinemedicine.symptombusinessMacular edemaAfliberceptmedicine.drugOphthalmology
researchProduct

European expert opinion on the management of invasive candidiasis in adults

2011

Item does not contain fulltext This report discusses the present status of antifungal therapy and treatment options for candidaemia, considered by experts in the field in Europe. A conference of 26 experts from 13 European countries was held to discuss strategies for the treatment and prevention of invasive candidiasis, with the aim of providing a review on optimal management strategies. Published and unpublished comparative trials on antifungal therapy were analysed and discussed. Commonly asked questions about the management of candidaemia were selected, and possible responses to these questions were discussed. Panellists were then asked to respond to each question by using a touchpad ans…

Invasive mycoses and compromised host Translational research [N4i 2]AdultMicrobiology (medical)medicine.medical_specialtyAntifungal Agentsmedicine.medical_treatmentPlacebo-controlled studyMEDLINEInvasive mycoses and compromised host Infection and autoimmunity [N4i 2]MicrobiologyMedicineHumanscandidaemiaCandidiasis InvasiveguidelinesIntensive care medicineWatchful Waitingtherapybusiness.industryTreatment optionsPathogenesis and modulation of inflammation Infection and autoimmunity [N4i 1]General MedicineInvasive candidiasisComparative trialAntibiotic Prophylaxismedicine.diseaseOptimal managementEuropeIntensive Care UnitsInfectious DiseasesconsensusExpert opinioncandidabusinessWatchful waitingClinical Microbiology and Infection
researchProduct